₹14,000 per month weight-loss shot is here to cash in on India’s obesity crisis

India's obesity crisis is intensifying, with big pharma companies like Eli Lilly and Novo Nordisk competing to introduce weight-loss drugs in the market. The economic impact is enormous, and local generics are preparing to offer more affordable alternatives to combat this growing health issue.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1XhQp5n
via IFTTT